[
  {
    "ts": null,
    "headline": "Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver?",
    "summary": "HOLX eyes a Breast Health rebound in Q4, backed by leadership changes, new strategy and Endomag momentum.",
    "url": "https://finnhub.io/api/news?id=18f0093b2a376ffcf30032a8b0588604921473b1264102846b56e44fb53a1ddd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753790700,
      "headline": "Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver?",
      "id": 136119721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "HOLX eyes a Breast Health rebound in Q4, backed by leadership changes, new strategy and Endomag momentum.",
      "url": "https://finnhub.io/api/news?id=18f0093b2a376ffcf30032a8b0588604921473b1264102846b56e44fb53a1ddd"
    }
  },
  {
    "ts": null,
    "headline": "Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche",
    "summary": "The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed",
    "url": "https://finnhub.io/api/news?id=80cce2c4a6b5656f1728f280feb7b727100f47c335d552d98cfacd4b0630d77c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753776120,
      "headline": "Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche",
      "id": 136117047,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed",
      "url": "https://finnhub.io/api/news?id=80cce2c4a6b5656f1728f280feb7b727100f47c335d552d98cfacd4b0630d77c"
    }
  },
  {
    "ts": null,
    "headline": "Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings",
    "summary": "Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Wednesday afternoon. Here’s what investors should know.",
    "url": "https://finnhub.io/api/news?id=c08de05498a06179983f338362c1372944d6277c2ffffa522c5bc4f5ea43cad8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753759093,
      "headline": "Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings",
      "id": 136113758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Wednesday afternoon. Here’s what investors should know.",
      "url": "https://finnhub.io/api/news?id=c08de05498a06179983f338362c1372944d6277c2ffffa522c5bc4f5ea43cad8"
    }
  }
]